Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “adenosine”

64 pharma patents match "adenosine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 64
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 64 pharmaceutical patents matching "adenosine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

64 results for “adenosine” · 30,257 patents in full index Clear search

  1. US 9969998

    Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same

    HALOZYME, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  2. US 9963450

    A3 adenosine receptor agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 8, 2018 · Expires May 3, 2038

    granted
  3. US 9549943

    A3 adenosine receptor ligands for use in treatment of a sexual dysfunction

    CAN-FITE BIOPHARMA LTD. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  4. US 9415105

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  5. US 9326978

    A3 adenosine receptor allosteric modulators

    THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES · Granted May 3, 2016 · Expires Apr 28, 2036

    granted
  6. US 9181253

    Adenosine receptor agonists, partial agonists, and antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  7. US 9018371

    Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted
  8. US 8987228

    Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis

    CAN-FITE BIOPHARMA LTD. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  9. US 8916570

    A3 adenosine receptor agonists and antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted
  10. US 8883500

    Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy

    Northwestern University · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted
  11. US 8796291

    A3 adenosine receptor antagonists and partial agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  12. US 8735407

    Purine derivatives as A3 adenosine receptor-selective agonists

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted
  13. US 8716301

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted
  14. US 8518957

    Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  15. US 8513214

    C4′-substituted-2-deoxyadenosine analogs and methods of treating HIV

    The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  16. US 8420664

    A3 adenosine receptor allosteric modulators

    THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  17. US 8349848

    Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptors

    Dogwood Pharmaceuticals, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted
  18. US 8263762

    Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists

    Dogwood Pharmaceuticals, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  19. US 8080554

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  20. US 7855202

    Imidazopyridine derivatives as A2B adenosine receptor antagonists

    Laboratories Almirall, S.A. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  21. US 7825126

    Purine derivatives as A3 and A1 adenosine receptor agonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  22. US 7790728

    Pyrazine derivatives useful as adenosine receptor antagonists

    Laboratories Almirall, S.A. · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted
  23. US 7767686

    Method of using adenosine receptor blockers during tissue ablation

    Covidien LP · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  24. US 7589075

    Use of an adenosine A3 receptor agonist for inhibition of viral replication

    CAN-FITE BIOPHARMA LTD. · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted